Micheal Niesman

Dr. Michael Niesman earned his Ph.D. in cell biology at University of Illinois and a Postdoctoral Fellowship at Louisiana State University. In the mid-1990s he was Assistant Professor of Ophthalmology, Pharmacology and Toxicology at University of Arkansas for Medical Scientist. He was Head of Ocular Pharmacology at Warner Lambert, Inc. He joined Pfizer and in time became Head of Ophthalmology Research. He is now Chief Scientific Officer at MingSight Pharmaceuticals. He contributed publications in peer-reviewed journals, is lead author on two patents and a contributor to a third patent. Dr. Niesman is a crucial member of Nano PharmaSolutions (NPS) Scientific Advisory Board because of his expertise in ocular pharmacology, ocular drug delivery and ocular drug development, a dosage form to which NPS intends devote a significant amount of its resources.